Donepezil
Data up to Jan 2025
Total Citations Per Year
Abstract
References (52)
How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations.
1992 • 1,582 citations
A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease
1998 • 1,575 citations
Diagnosis and Treatment of Alzheimer Disease and Related Disorders
1997 • 925 citations
Multiattribute Utility Function for a Comprehensive Health Status Classification System
1996 • 880 citations
Donepezil Improves Cognition and Global Function in Alzheimer Disease<subtitle>A 15-Week, Double-blind, Placebo-Controlled Study</subtitle>
1998 • 753 citations
The Efficacy and Safety of Donepezil in Patients with Alzheimer's Disease: Results of a US Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial
1996 • 730 citations
The US economic and social costs of Alzheimer's disease revisited.
1994 • 600 citations
The Effects of Donepezil in Alzheimer’s Disease – Results from a Multinational Trial<sup>1</sup>
1999 • 581 citations
Cholinesterase Inhibitors in the Treatment of Alzheimer??s Disease
1998 • 369 citations
Canadian study of health and aging: study methods and prevalence of dementia.
1994 • 318 citations
Long-term tacrine (Cognex) treatment
1996 • 300 citations
Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: an interim analysis of the results of a US multicentre open label extension study
1998 • 289 citations
Alzheimer's Disease Care: Costs And Potential Savings
1998 • 252 citations
Relation between severity of Alzheimer's disease and costs of caring.
1998 • 238 citations
Cost-effectiveness of donepezil in the treatment of mild or moderate Alzheimer’s disease
1999 • 236 citations
Economic Considerations in Alzheimer's Disease
1998 • 197 citations
Cognitive Function and the Costs of Alzheimer Disease
1997 • 173 citations
Tacrine
1994 • 139 citations
Economic Evaluation of Donepezil for the Treatment of Alzheimer's Disease in Canada
1999 • 126 citations
Donepezil Use in Alzheimer Disease
1998 • 126 citations
Donepezil
1997 • 120 citations
Alzheimer's disease: the burden of the illness in England.
1993 • 118 citations
Donepezil: an anticholinesterase inhibitor for Alzheimer’s disease
1997 • 104 citations
Economic impact of Alzheimer's disease in the United Kingdom
1999 • 99 citations
An economic evaluation of donepezil in the treatment of Alzheimer's disease
1998 • 95 citations
Pharmacotherapy for people with Alzheimer's disease: a Markov-cycle evaluation of five years' therapy using donepezil
1998 • 92 citations
Guidelines on drug treatments for Alzheimer's disease
1997 • 80 citations
Recent Developments in the Drug Treatment of Alzheimer??s Disease
1999 • 74 citations
Practice guideline for the treatment of patients with Alzheimer's disease and other dementias of late life. American Psychiatric Association [published erratum appears in Am J Psychiatry 1997 Aug;154(8):1180]
1997 • 64 citations
The economic impact of tacrine in the treatment of Alzheimer's disease
1997 • 59 citations
The perspective of the person with Alzheimer disease: which outcomes matter in early to middle stages of dementia?
1997 • 55 citations
Emerging Antidementia Drugs: A Preliminary Ethical View
1998 • 48 citations
Issues in the economic evaluation of treatment for dementia. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
1997 • 45 citations
Epidemiology of Alzheimer's disease.
1997 • 45 citations
An Outline For a Cost-Effectiveness Analysis of a Drug For Patients With Alzheimer??s Disease
1998 • 45 citations
Treatment of Alzheimer disease with tacrine: a cost-analysis model.
1997 • 42 citations
The Cost of Alzheimerʼs Disease
1996 • 40 citations
First International Pharmacoeconomic Conference on Alzheimerʼs Disease: Report and Summary
1998 • 31 citations
Drug Treatment of Alzheimerʼs Disease
1996 • 29 citations
Guidelines for the Appropriate Use of Cholinesterase Inhibitors in Patients with Alzheimer??s Disease
1999 • 28 citations
A Review of Quality of Life in Alzheimer??s Disease
1998 • 27 citations
Pharmacoeconomic Models in Disease Management
1998 • 22 citations
Methods of cost-effectiveness analysis in the assessment of new drugs for Alzheimer's disease
1997 • 19 citations
Drug Treatments for Alzheimer??s Disease
1999 • 19 citations
Donepezil (Aricept) therapy for Alzheimer's disease.
1997 • 19 citations
Epidemiology of dementias
1998 • 17 citations
Cholinesterase Inhibitors in Alzheimer??s Disease
1999 • 16 citations
Beyond Tacrine
1998 • 14 citations
The Pharmacoeconomics of Dementia Therapies
1997 • 14 citations
Measuring Outcomes in Alzheimer??s Disease Research
1999 • 9 citations
Which outcomes matter in Alzheimer disease and who should define them?
1997 • 8 citations
Donepezil update.
1998 • 2 citations